Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Roivant Sciences Ltd shares valued at $5,735,850 were sold by Venker Eric on Oct 07 ’25. At $16.15 per share, Venker Eric sold 355,161 shares. The insider’s holdings dropped to 1,504,959 shares worth approximately $24.12 million following the completion of this transaction.
Also, Venker Eric sold 171,396 shares, netting a total of over 2,800,611 in proceeds. Following the sale of shares at $16.34 each, the insider now holds 1,504,959 shares.
Before that, Venker Eric had sold 138,602 shares from its account. In a trade valued at $2,245,352, the President & Immunovant CEO traded Roivant Sciences Ltd shares for $16.20 each. Upon closing the transaction, the insider’s holdings decreased to 138,602 shares, worth approximately $24.12 million.
As published in their initiating research note from Citigroup on September 02, 2025, Roivant Sciences Ltd [ROIV] has been a Buy and the price target has been revised to $16. As of February 15, 2024, Wolfe Research has initiated its “an Outperform” rating for ROIV. Earlier on January 05, 2024, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for ROIV stock.
Analyzing ROIV Stock Performance
On last trading session, Roivant Sciences Ltd [NASDAQ: ROIV] plunged -0.56% to $16.03. The stock’s lowest price that day was $15.96, but it reached a high of $16.34 in the same session. During the last five days, there has been a surge of approximately 1.78%. Over the course of the year, Roivant Sciences Ltd shares have jumped approximately 40.86%. Shares of the company reached a 52-week high of $16.79 on 10/06/25 and a 52-week low of $8.73 on 04/07/25.
Support And Resistance Levels for Roivant Sciences Ltd (ROIV)
According to the 24-hour chart, there is a support level at 15.88, which, if violated, would cause prices to drop to 15.73. In the upper region, resistance lies at 16.26. The next price resistance is at 16.49. RSI (Relative Strength Index) is 74.80 on the 14-day chart, showing overbought technical sentiment.
Is Roivant Sciences Ltd subject to short interest?
Stocks of Roivant Sciences Ltd saw a sharp steep in short interest on 2025-09-15 dropping by -1.88 million shares to 36.21 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 38.09 million shares. A decline of -5.19% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.45 of the overall float, the days-to-cover ratio (short ratio) decline to 5.45.
Which companies own the most shares of Roivant Sciences Ltd (ROIV)?
In terms of Roivant Sciences Ltd share price expectations, FactSet research, analysts set an average price target of 20 in the next 12 months, up nearly 24.07% from the previous closing price of $16.12. Analysts anticipate Roivant Sciences Ltd stock to reach 21 by 2025, with the lowest price target being 20. In spite of this, 7 analysts ranked Roivant Sciences Ltd stock as Buy at the end of 2025. On December 12, 2023, Deutsche Bank assigned a price target of “a Buy” to the stock and initiated coverage with a $14.
